We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.5B
AUM Growth
+$193M
(+1.7%)
Cap. Flow
-$192M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
1,049
New
36
Increased
599
Reduced
353
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$60.8M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$23.6M |
| 3 |
MPLX
MPLX
|
+$18.5M |
| 4 |
Western Midstream Partners
WES
|
+$13.9M |
| 5 |
Newell Brands
NWL
|
+$7.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$128M |
| 2 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$96.8M |
| 3 |
Plains All American Pipeline
PAA
|
+$55.6M |
| 4 |
Enterprise Products Partners
EPD
|
+$19.3M |
| 5 |
Microsoft
MSFT
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 64.17% |
| 2 | Technology | 5.57% |
| 3 | Healthcare | 3.84% |
| 4 | Consumer Discretionary | 3.76% |
| 5 | Financials | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
KeyCorp
KEY
$24.3B
| $187K | ﹤0.01% |
20,280
-11,174
| -36% | -$117K |
|
|
NBP
977
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $183K | ﹤0.01% |
61,333
+6,659
| +12% | +$21.4K |
|
978
InflaRx
IFRX
$256M
| $177K | ﹤0.01% |
+39,778
| New | +$178K |
|
979
Hudbay
HBM
$9.92B
| $155K | ﹤0.01% |
32,300
+14,594
| +82% | +$71.3K |
|
980
HighPeak Energy
HPK
$967M
| $152K | ﹤0.01% |
13,955
+105
| +0.8% | +$1.77K |
|
981
Karyopharm Therapeutics
KPTI
$168M
| $150K | ﹤0.01% |
+5,587
| New | +$241K |
|
|
TGB
982
Trekor Metals
TGB
$2.56B
| $143K | ﹤0.01% |
100,145
+34,842
| +53% | +$52.1K |
|
983
Ivanhoe Electric
IE
$1.43B
| $132K | ﹤0.01% |
+10,099
| New | +$128K |
|
|
KZR
984
DELISTED
Kezar Life Sciences
KZR
| $130K | ﹤0.01% |
5,322
+809
| +18% | +$21.1K |
|
985
Altimmune
ALT
$539M
| $128K | ﹤0.01% |
36,233
+3,768
| +12% | +$16.9K |
|
|
WHWK
986
Whitehawk Therapeutics
WHWK
$183M
| $123K | ﹤0.01% |
17,965
+1,891
| +12% | +$14.7K |
|
987
PDS Biotechnology
PDSB
$38.1M
| $114K | ﹤0.01% |
22,658
+3,880
| +21% | +$25.4K |
|
|
SLI
988
Standard Lithium
SLI
$517M
| $80.5K | ﹤0.01% |
17,896
-7,625
| -30% | -$29.7K |
|
|
WRN
989
Western Copper and Gold
WRN
$485M
| $63.9K | ﹤0.01% |
41,794
+15,734
| +60% | +$26.4K |
|
|
NAK
990
Northern Dynasty Minerals
NAK
$885M
| $42K | ﹤0.01% |
175,112
+61,781
| +55% | +$14.1K |
|
|
EXK
991
Endeavour Silver
EXK
$2.32B
| $41.3K | ﹤0.01% |
+14,288
| New | +$50.5K |
|
|
SVM
992
Silvercorp Metals
SVM
$2.13B
| $31.5K | ﹤0.01% |
+11,181
| New | +$38K |
|
|
TMQ
993
Trilogy Metals
TMQ
$522M
| $25.4K | ﹤0.01% |
42,767
+18,787
| +78% | +$10.6K |
|
|
PLM
994
DELISTED
PolyMet Mining Corp.
PLM
| $8.68K | ﹤0.01% |
+10,983
| New | +$16.5K |
|
995
Arbutus Biopharma
ABUS
$865M
| – | – |
-107,107
| Closed | -$325K |
|
|
AFMD
996
DELISTED
Affimed
AFMD
| – | – |
-9,615
| Closed | -$71.7K |
|
997
First Majestic Silver
AG
$8.05B
| – | – |
-12,741
| Closed | -$91.9K |
|
|
AGEN
998
Agenus
AGEN
$249M
| – | – |
-10,232
| Closed | -$305K |
|
999
Advanced Micro Devices
AMD
$851B
| – | – |
-2,189
| Closed | -$215K |
|
1000
Arcutis Biotherapeutics
ARQT
$3.42B
| – | – |
-40,244
| Closed | -$443K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ALPS Advisors held 1,049 positions worth $11.5B, up 1.7% from $11.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
ALPS Advisors's Q2 2023 filing shows 36 new, 599 increased, 353 reduced and 55 closed positions. Its largest new stake was Nextpower Inc: 131,086 shares worth $5.22M. The largest sale was Magellan Midstream Partners, L.P., an estimated $128M.
By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.
- ALPS Advisors's largest Q2 2023 buy was Nextpower Inc: 131,086 shares worth $5.22M.
- ALPS Advisors added most to Hess Midstream in Q2 2023, an estimated $60.8M increase.
- ALPS Advisors's biggest Q2 2023 reduction was Magellan Midstream Partners, L.P., cutting an estimated $128M.
- ALPS Advisors fully exited Roivant Sciences in Q2 2023, selling an estimated $3.69M.
- ALPS Advisors's ten largest holdings make up 54% of its $11.5B portfolio in Q2 2023.
- ALPS Advisors opened 36 new positions and closed 55 in Q2 2023.
- ALPS Advisors's portfolio value rose 1.7% quarter-over-quarter to $11.5B.
Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.